Search

everythinglearnresearchcommunity

for

Search:↓

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

A new gene mutation causes vitamin D-resistant rickets and hair loss in two siblings.

The study found that variations in hair protein genes are likely due to evolutionary deletions or duplications.

Removing the VDR gene in skin cells reduces their growth and affects hair-related genes.

Activating TLR3 helps improve skin and hair follicle regeneration after wounds.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Certain genes are linked to the risk of developing Alopecia Areata.

Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

People with acne have more CD4+ immune cells in their skin than healthy people.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Mutations in Plcd1 and Plcd3 together cause severe hair loss in mice.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Hair follicle cells resist turning into skin cells.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Vitamin D Receptor is needed for hair growth in mice but not for skin stem cell maintenance.

Desmocollin 1 and 3 have distinct patterns in human tissues, with Dsc1 in specific skin and hair layers and Dsc3 in various epithelial layers.

VEGF and VEGFR-2 genes influence feather maturity, and specific genetic markers can improve chicken breeding.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

VDDR I and II are genetic disorders affecting vitamin D use, causing rickets, with VDDR I treatable by vitamin D supplements and VDDR II needing high doses and calcium.

Expressing the human vitamin D receptor in skin cells prevents hair loss in certain mice.

Vimentin and keratin help viruses spread and could be targets for antiviral treatments.

TLR3 activation helps improve skin and hair follicle healing in mice.

A genetic mutation caused severe rickets and alopecia in an Indian patient, but high-dose calcium and phosphate treatment improved their condition.

A gene mutation causes lanceolate hair in rats by disrupting hair shaft integrity.

Vitamin D receptor FokI gene variation is not linked to alopecia areata.